SIBN
Si-Bone, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$21.23Close
$926.6MMarket cap
$11.61 – $22.4152-week range
Nov 2, 2026Next report · after the close
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 87 · stronger than 87% of stocks over 12 months
Cautions
- Results soon Nov 2, 2026, in 1 day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
5%
1wk
down 1.2%
price change
1mo
up 12.9%
price change
12-month return
up 40%
market up 11% ·
its own up 28%
F-score
5 / 9
Mixed
Altman Z
7.96
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
5.2×
price / book
Earnings yield
down 2.4%
EBIT / enterprise value
Cheaper than
24%
of the market · expensive
Revenue growth
up 20%
year on year
EPS growth
—
latest quarter
Sales growth
up 15%
latest quarter · +4 pts
ROE
down 11%
return on equity
Free cash margin
down 5%
-$9.1M FCF
D/E
0.20
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- operating cash flow is negative
- took on more long-term debt
- issued more shares
- profitability improving
- profits backed by cash
- short-term liquidity improved
- gross margin widened
- assets working harder
Trade setup
ATR%
3.8%
$0.81 a day · 2×ATR $19.61
RS
87 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
2.1×
vs 50-day average
Up/down volume
0.93
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 3.7% over the year, from 42m to 44m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 3, 2026
Results reaction
Aug 3, 2026+1% vs market2 sessions after results
Financials
- Gross 80%
- Net -9%
- Free cash -5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $73.4M | $90.2M | $106.4M | $138.9M | $167.2M | $200.9M |
| Gross margin | 88% | 88% | 85% | 79% | 79% | 80% |
| Operating income | -$38.6M | -$51.7M | -$59.6M | -$46.9M | -$35.2M | -$22.3M |
| Net income | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| Net margin | -60% | -63% | -58% | -31% | -18% | -9% |
| Earnings per share | -$1.50 | -$1.71 | -$1.79 | -$1.13 | -$0.75 | -$0.44 |
| Free cash flow | -$33.2M | -$45.9M | -$51.2M | -$26.5M | -$22.9M | -$9.1M |
| Free cash margin | -45% | -51% | -48% | -19% | -14% | -5% |
| Cash | $53.6M | $63.4M | $20.7M | $33.3M | $34.9M | $42.2M |
| Long-term debt | $39.5M | $35.0M | $35.2M | $36.1M | $35.5M | $35.6M |
| Shareholders' equity | $169.4M | $134.4M | $98.3M | $169.4M | $167.0M | $177.5M |
| Shares outstanding | 32.58m | 33.67m | 34.73m | 40.69m | 42.09m | 43.65m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| May 11, 2026 | Quarterly ↗ | Mar 31, 2026 | 41d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 10, 2025 | Quarterly ↗ | Sep 30, 2025 | 41d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 11, 2026 | Material agreement · New obligation · Other events ↗ |
| Aug 3, 2026 | Results ↗ |
| Jun 8, 2026 | Material agreement · New obligation · Shareholder vote ↗ |
| May 11, 2026 | Results ↗ |
| Feb 23, 2026 | Material agreement · Results · Director or officer change ↗ |
| Jan 12, 2026 | Results · Regulation FD ↗ |
| Nov 10, 2025 | Results · Director or officer change ↗ |
| Aug 4, 2025 | Results · Director or officer change ↗ |
| Jun 6, 2025 | Shareholder vote ↗ |
| May 5, 2025 | Results ↗ |
| Feb 24, 2025 | Results ↗ |
| Jan 13, 2025 | Results ↗ |